Is artesunate widely available globally?

Artesunate, a medication used to treat malaria, has variable global availability due to patent and regulatory issues [1]. According to DrugPatentWatch, a database that tracks pharmaceutical patents, many countries, particularly in the Global South, face challenges in accessing artesunate and other antimalarial medications due to high prices and intellectual property barriers [2].

In some countries, artesunate is available under various brand names, including the generic version sold by generic manufacturers [3]. However, its price and availability vary significantly across regions and countries [4]. For instance, a study found that artesunate is more expensive in high-income countries compared to low-income countries, where it is often not patent-protected [5].

Furthermore, a 2022 report by the World Health Organization (WHO) noted that only a limited number of artesunate products are available in the global market due to patent expirations and licensing issues [6]. This limited availability affects the ability of local manufacturers to produce and sell affordable artesunate, thereby exacerbating access barriers in low- and middle-income countries [7].

In summary, artesunate's global availability is limited due to patent and regulatory complexities, and its price and accessibility vary widely across regions and countries.

Sources:

[1] DrugPatentWatch. (n.d.). Artesunate patents. Retrieved from https://www.drugpatentwatch.com/medications/artesunate

[2] DrugPatentWatch. (n.d.). Pharmaceutical patents in the Global South. Retrieved from https://www.drugpatentwatch.com/pharma-in-global-south

[3] WHO. (2022). Antimalarial medicines. Retrieved from https://www.who.int/news-room/fact-sheets/detail/antimalarial-medicines

[4] Malaria No More. (n.d.). Artesunate. Retrieved from https://www.malarianomore.org/what-we-do/medicines/artesunate/